This inventor holds 2 USPTO granted patents. Top assignee: Elder Pharmaceuticals Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Rajiv R Sakhardande: Innovator in Pharmaceutical Compounds
Introduction
Rajiv R Sakhardande is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 2 patents to his name, Sakhardande continues to push the boundaries of innovation in medicine.
Latest Patents
Sakhardande's latest patents include groundbreaking work on anti-inflammatory compounds. His patents detail biphenyl compounds of Formula (I) and Formula (II), along with their pharmaceutically acceptable salts, solvates, or prodrugs. These compounds are disclosed to exhibit anti-inflammatory properties, providing new avenues for treatment. Additionally, he has developed a process for the preparation of imidazopyridines. This process involves reacting 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine with oxalyl chloride, followed by conversion to oxoacetic acid, ultimately leading to the compound of Formula (I).
Career Highlights
Rajiv R Sakhardande is currently associated with Elder Pharmaceuticals Ltd., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the company's research and development efforts.
Collaborations
Sakhardande collaborates with talented professionals in his field, including Vithal Kulkarni and Nilesh Wagh. These collaborations enhance the innovative capacity of their projects and contribute to the success of their pharmaceutical endeavors.
Conclusion
Rajiv R Sakhardande is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to anti-inflammatory research. His work continues to impact the field positively, paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile